GZMM and Miyoshi myopathy: SMM patients that progressed to MM showed 76 differentially expressed genes when compared to SMM patients who showed no progression during follow up, with an increase in 63 including molecules involved in immune response activation such as TNF, IL-1B and granzyme M (Figure 5D).